Base Molecular Resonance™ Technologies has secured $5 million in initial commitments toward its ongoing $15 million investment initiative.

Investor Enthusiasm Reflects the Transformative Potential of BMRT's Quantum Physics-Driven Security Technology

STUART, Fla., March 4, 2025 /PRNewswire/ -- Base Molecular Resonance^™ Technologies (BMRT), the pioneering force behind quantum physics-driven security/medical/military innovations, today announced that it has secured $5 million in initial commitments toward its ongoing $15 million investment initiative. The strong initial response underscores the market's recognition of BMRT's groundbreaking technology and its potential to redefine security and public safety.

A New Era in Threat Detection

BMRT's multi-patented Base Molecular Resonance™ technology represents a paradigm shift in security. Harnessing molecular resonance at the subatomic level, BMR™ technology enables the instantaneous and remote detection of all elements on the periodic table with complete accuracy, penetrating walls, vehicles, and solid barriers. This revolutionary capability offers law enforcement, national security agencies, and private security firms an unprecedented advantage in identifying and neutralizing threats before they materialize.

"We are experiencing an extraordinary level of enthusiasm from investors who recognize the seismic impact of our technology," said Robert "Bo" Short, Co-Founder & CEO of BMRT. "This is not just another advancement in security; it is a complete reinvention of how we detect and prevent threats. Our investor commitments reflect confidence in both our innovation and the massive market opportunity ahead."

Building Toward a Safer Future

BMRT Security, Inc. is positioned to deploy this next-generation security solution across critical infrastructure, including:

• Airports, public transit, maritime, and border security
• Schools, universities, and government buildings
• Stadiums, event venues, and corporate headquarters
• Private security, executive protection, and law enforcement operations

BMRT's $1.8 billion U.S. IP licensing valuation, conducted by an independent global firm, further validates the enormous potential of this technology. The company's valuation projects an additional $3.5 billion in value through international expansion, totaling $5.3 billion.

Breakthrough Backed by Independent Third-Party Validation

BMRT's Base Molecular Resonance^™ (BMR^™) technology has been rigorously tested and independently validated in a landmark study conducted by the Centre for Applied Innovation at York St. John University in England. The third-party study confirmed BMRT's 100% accuracy in detecting gunpowder, illicit drugs, and other high-threat materials in both blind and double-blind tests, with no false positives or false negatives.

Professor Philippe B. Wilson, PhD, the study's lead scientist, whose PhD is in Quantum Chemistry and his focus is in Molecular Resonance, is the Associate Pro Vice-Chancellor for Innovation and Knowledge Exchange, and Director of the Centre for Applied Innovation at York St John University located in York, England, emphasized the significance of these findings:

"Having assessed and evaluated BMRT's technology, it is clear to me that I have never seen anything quite like it. Indeed, breakthrough technologies which can support every aspect of society are few and far between, leading to multinational success and Nobel prize-worthy impact."

York St. John University's validation process utilized controlled testing environments, with blind and double-blind tests, to assess BMR™ technology's ability to remotely detect and identify molecular signatures through walls, vehicles, and solid barriers. The study's results confirm that BMRT outperforms all conventional threat detection methods, offering instantaneous, non-intrusive security screening at an unprecedented level of precision.

Join the Movement to Revolutionize Security

BMRT Security, Inc. invites strategic investors to participate in this seed round as it advances the global deployment of its security technology.

"We are at a pivotal moment in history," said Lee Duke, Co-Founder & President of BMRT. "The need for real security solutions has never been greater. Every dollar invested in BMRT Security, Inc. accelerates the adoption of a technology that will save lives, prevent attacks, and make our communities safer. Our early traction is a clear signal that the market understands the urgency and scale of this opportunity."

About Base Molecular Resonance^™ Technologies (BMRT)

BMRT has discovered a new area of Quantum Physics that utilizes resonant frequencies to detect particle interactions at subatomic levels. This technology, called Base Molecular Resonance™ (BMR™), can detect any compound or biological substance, including every element on the periodic table, and up to 200 cancers and other diseases. With over 20 years of prototyping and testing proving its unmatched detection capabilities, BMR™ has the potential to save millions of lives by pinpointing weapons, explosives, and other physical threats both up close and at great distances, and detecting cancers and other diseases long before they present clinical symptoms. The non-invasive, harmless, and instant scan has broad implications in cancer diagnostics, public safety, law enforcement, security, and military services.

For more information, visit www.BMRT.io.

Investment Inquiries

Robert "Bo" Short
Co-Founder & CEO
[email protected]

Media Contact

Bryan Adams
[email protected]
800.522.4718 Ext. 1

Forward-Looking Statements: This press release contains forward-looking statements regarding anticipated market opportunities and business expansion. Actual results may vary based on industry developments and external factors.

SOURCE Base Molecular Resonance Technologies, LLC